Document is current

Any future updates will be listed below

Efficacy and safety of IL-23p19 antagonists versus placebo in inflammatory bowel disease: a systematic review and meta‑analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s11096-025-02029-4

Published Online: 2025-11-13

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark